Alexandria Real Estate Equities
ARE
#2086
Rank
NZ$16.08 B
Marketcap
NZ$92.83
Share price
1.38%
Change (1 day)
-43.79%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

P/S ratio for Alexandria Real Estate Equities (ARE)

P/S ratio as of February 2026 (TTM): 3.24

According to Alexandria Real Estate Equities 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.4566. At the end of 2025 the company had a P/S ratio of 4.80.

P/S ratio history for Alexandria Real Estate Equities from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20254.80-14.75%
20245.64-27.28%
20237.75-16.47%
20229.28-44.49%
202116.730.53%
202012.8-0.49%
201912.932.25%
20189.73-13.23%
201711.214.08%
20169.8322.88%
20158.00-9.14%
20148.8020.55%
20137.300.05%
20127.30-14.75%
20118.56-2.37%
20108.7721.13%
20097.2439.2%
20085.20-48.94%
200710.2-14.54%
200611.926.22%
20059.440.05%
20049.4412.4%
20038.4021.7%
20026.901.27%
20016.81

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Pfizer
PFE
2.46-23.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
15.8 388.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
5.69 75.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
6.51 101.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
4.32 33.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.62-19.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
13.6 319.09%๐Ÿ‡บ๐Ÿ‡ธ USA